Introduction
There is wide consensus that methadone maintenance treatment reduces drug use and drug injection among opiate addicts.'-3 While the prescribed dosage level of methadone, an opioid agonist, has long been recognized to be related to reduction of illicit opiate use,>7 standards for methadone dosages remain controversial!/"1' In most treatment settings, the aim of methadone maintenance is to achieve steady opioid receptor coverage so as to prevent abstinence symptoms and reduce opioid craving.5.6 Opioid blockade (i.e., blocking of the euphoric effects of other opiates4) occurs with relatively high dosages of methadone and is the theoretical basis for the 60-to 80-mg/day dosage recommendation of the National Institute on Drug Abuse (NIDA).' 8 Despite this recommendation, most methadone patients are maintained on dosages well below 60 mg/day. [8] [9] Empirical evidence for high-dose methadone maintenance treatment remains incomplete. Most While heroin use was lowest for patients with the greatest durations of time in treatment, the association between methadone dose and heroin use was independent of time in treatment. Heroin was used by 51.6% (83/161) of patients in treatment for less than 1 year. For those in treatment from 1 to 2 years, the overall percentage using heroin was 41.7% (25/60). In contrast, only 17.9% (77/431) of patients in treatment for more than 2 years used heroin. The association between heroin use and methadone dose was examined separately for those in treatment 2 years or less and for those in treatment more than 2 years. Higher odds of heroin use for methadone dosages under 70 mg/day relative to higher dosages (Table 2) were found (odds ratios of 2.3 and 1.9, respectively).
Heroin and Cocaine Use during Treatment
Heroin use during treatment was associated with cocaine use. Of the 337 individuals who used cocaine during the observation period, 148 (43.9%) also used heroin. In contrast, only 38 of 315 (11.8%) nonusers of cocaine used heroin during treatment (OR = 6.1, 95% CI = 4.1, 9.1). This association was independent of methadone dose. Odds ratios for the associations between cocaine use and continued heroin use were 5.1 and 4.4 in the low methadone dose and high methadone dose groups, respectively. The doseadjusted overall odds ratio (MantelHaenszel) was 4.9 (95% CI = 3.4, 7.2); there was no evidence of odds ratio heterogeneity (Breslow-Day test, P = .09). In comparison with nonusers of cocaine, cocaine users had a consistently higher degree of heroin use at each dosage level (Figure 1 evidence of impaired adrenal function due to methadone itself,33 34it is possible that stress reactions alter the thresholds at which opiate abstinence symptoms, craving, and blockade occur. In this study, several markers of social disadvantage and, by inference, greater exposure to stressors were found to be related to cocaine use: low income (<$10 000 per year), low educational attainment, homelessness, unemployment, and self-identification with a racial or ethnic minority group. Of these, homelessness was independently associated with continued heroin use during treatment; however, our study design was inadequate to address the interrelationship of cocaine use, stress, and methadone metabolism.
A third possible explanation may be that differences in methadone metabolism and, thus, opioid receptor coverage exist between cocaine users and nonusers. There is no evidence of a direct effect of cocaine on methadone metabolism; however, without direct measurement of methadone clearance, one cannot rule out differences in metabolism between users and nonusers.35 Agents known or strongly suspected to accelerate hepatic metabolism and thus decrease the bioavailability of methadone include rifampin and phenytoin. 23 Acohol use has been associated with both increased and decreased plasma methadone levels.2324 These agents have the potential to confound the association between cocaine and heroin use. There was no indication of the use of either rifampin or phenytoin among patients in the sample at the time of study. In our analysis, heavy alcohol intake was not associated with cocaine use or with heroin use.
In addition to the analyses described above, we conducted a methodological substudy of the impact of treatment dropout patterns on the sample chosen for study. This substudy (reported elsewhere36) found that while there was a faster rate of dropout for patients on low-dose methadone, selection due to dropout was not sufficient to seriously bias the findings of the study. The estimated odds ratio for the association between methadone dose and heroin use without differential dropout was 2.7, in comparison with the observed odds ratio of 2.1. Examination of sampling factors related to cocaine use and heroin use showed negligible bias in this effect measure.
Conchusions
These data strongly support the use of high-dose methadone maintenance treatment to control illicit opioid (heroin) use whether or not patients also use cocaine. As in other studies,4'7'11'12'14 highdose methadone appears to be a critical factor in cessation of heroin use. The strong, independent association between cocaine use and continued use of heroin during methadone treatment has not been reported previously and requires further study. The full distribution of dose-associated opioid withdrawal, craving, and blockade phenomena and modifying factors should be examined prospectively in conjunction with methadone plasma levels. 35 Patients in methadone treatment have long maintained that cocaine "eats up the methadone"26; whether this is simply a perception without neurological, metabolic, or other meaningful biologic mechanisms, however, remains to be determined. O
